论文部分内容阅读
我院定期随访用药的6岁以下小儿哮喘26例,经小型折叠式储雾囊吸入必可酮为主要治疗,辅以转移因子、多种维生素,治疗前平均分为6.42±0.60分,治疗后平均分为2.23±1.70分,经统计学处理,t=11.97,P<0.001,差异非常显著。26例中无效2例,疗程均不足3个月,有效15例(57.69％),显效9例(34.62％),总有效率为92.31％。幼小儿童哮喘与感染密切相关,传统的以抗生素治疗有弊无利,强调应用吸入消炎剂的同时,增强免疫功能,预防感染,减少发作,并认为通过储雾囊吸入消炎剂,在幼小儿童中行之有效。
Our hospital regular follow-up medication in children under 6 years of age, 26 cases of asthma in children, the small folding storage capsule inhaled ketones as the main treatment, supplemented by transfer factor, multivitamins, before treatment, the average was divided into 6.42 ± 0.60 points after treatment The average was 2.23 ± 1.70 points, after statistical analysis, t = 11.97, P <0.001, the difference was significant. Among the 26 cases, 2 cases were ineffective and the courses of treatment were less than 3 months, 15 cases were effective (57.69%), 9 cases (34.62%) were effective, and the total effective rate was 92.31%. Children with asthma and infection are closely related to the traditional advantages and disadvantages of antibiotic treatment, emphasizing the use of inhaled anti-inflammatory agents at the same time, enhance immune function, prevent infection and reduce seizures, and that through the aerosol inhalation of anti-inflammatory agents, young children in the line Effective.